Aptose Biosciences Stock (NASDAQ: APTO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 97.420K |
Day Range | - - - |
52 Wk Range | 1.200 - 8.700 |
Market Cap | $22.005M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.55% |
Days to Cover | 1.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aptose Biosciences (NASDAQ: APTO) through any online brokerage.
There are no as such competitors for Aptose Biosciences.
The latest price target for Aptose Biosciences (NASDAQ: APTO) was reported by Piper Sandler on Wednesday, April 3, 2024. The analyst firm set a price target for 5.00 expecting APTO to rise to within 12 months (a possible 257.14% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Aptose Biosciences (NASDAQ: APTO) is $1.4 last updated April 15, 2024 at 7:03 PM EDT.
There are no upcoming dividends for Aptose Biosciences.
Aptose Biosciences’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Aptose Biosciences.
Aptose Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.